Advertisement
Screener

Grace Therapeutics, Inc. (GRCE) Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments

2.8 / 5 stars · 68/120 Roast Me

Grace Therapeutics, Inc. Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments

Grace Therapeutics, Inc. (GRCE) reported Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments of -CAD 12.77 million for the 13-month period ending 2017-03-31, per its 20-F filed 2019-06-26.

Discontinued › Notes

ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments · last filed 2019-06-26

Period endCash Flows From Used In Decrease Increase In Shortterm Deposits And Investments 12 monthCash Flows From Used In Decrease Increase In Shortterm Deposits And Investments 13 month
2017-03-31-12.77M CAD
20-F · filed 2019-06-26
2017-02-28-12.77M CAD
20-F · filed 2019-06-26
2016-02-29-11.95M CAD
20-F · filed 2018-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
VERU INC. (VERU)United States$0.043B-3.93
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98